MENU
+Compare
PCSA
Stock ticker: NASDAQ
AS OF
Jul 25 closing price
Price
$0.24
Change
-$0.01 (-4.00%)
Capitalization
6.36M

PCSA Processa Pharmaceuticals Forecast, Technical & Fundamental Analysis

Processa Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on utilizing its regulatory science approach in the development of Next Generation Chemotherapy (NGC) oncology drug products... Show more

PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for PCSA with price predictions
Jul 25, 2025

PCSA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for PCSA turned positive on July 16, 2025. Looking at past instances where PCSA's MACD turned positive, the stock continued to rise in of 38 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 66 cases where PCSA's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on July 24, 2025. You may want to consider a long position or call options on PCSA as a result. In of 73 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where PCSA advanced for three days, in of 210 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

PCSA moved below its 50-day moving average on June 25, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for PCSA crossed bearishly below the 50-day moving average on June 27, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCSA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.803) is normal, around the industry mean (18.028). P/E Ratio (0.000) is within average values for comparable stocks, (59.593). PCSA's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.512). Dividend Yield (0.000) settles around the average of (0.044) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (278.844).

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. PCSA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PCSA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

View a ticker or compare two or three
PCSA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

PCSA is expected to report earnings to fall 66.67% to -10 cents per share on March 28

Processa Pharmaceuticals PCSA Stock Earnings Reports
Q4'23
Est.
$-0.10
Q1'25
Beat
by $0.26
Q4'24
Beat
by $0.06
Q3'23
Beat
by $0.02
Q2'23
Beat
by $0.05
The last earnings report on May 08 showed earnings per share of -30 cents, beating the estimate of -56 cents. With 4.19M shares outstanding, the current market capitalization sits at 6.36M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7380 Coca Cola Drive
Phone
+1 443 776-3133
Employees
13
Web
https://www.processapharmaceuticals.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PNR103.080.23
+0.22%
Pentair plc
SMTK0.96N/A
N/A
SmartKem Inc.
PLOW29.25-0.17
-0.58%
Douglas Dynamics
TDTH1.34-0.01
-0.74%
Trident Digital Tech Holdings Ltd
APLS19.59-0.50
-2.49%
Apellis Pharmaceuticals

PCSA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, PCSA has been loosely correlated with OPORF. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if PCSA jumps, then OPORF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCSA
1D Price
Change %
PCSA100%
-3.34%
OPORF - PCSA
51%
Loosely correlated
N/A
INO - PCSA
38%
Loosely correlated
-2.65%
ONCO - PCSA
34%
Loosely correlated
+14.96%
LVTX - PCSA
27%
Poorly correlated
-2.05%
IMNN - PCSA
26%
Poorly correlated
-7.24%
More